---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-097790"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:22:19.841676+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents CFO Alexander D'Amico resigns weeks after appointment

## Summary
- Alexander D'Amico resigned as CFO effective August 28, 2023 under mutual termination agreement.
- D'Amico was appointed on July 10, 2023 (effective August 7, 2023) and served less than a month.
- No severance payments or equity vesting; mutual non-disparagement and release provisions apply.
- Kathleen Bloch continues as Interim CFO under existing consulting arrangement.

## SEC filing metadata
- accession: 0001104659-23-097790
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465923097790/0001104659-23-097790-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465923097790/tm2325277d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-097790
- JSON: https://secwatch.observer/filing/0001104659-23-097790.json
- Plain text: https://secwatch.observer/filing/0001104659-23-097790.txt

## Key facts
- Executive change
  Alexander D'Amico resigned as Chief Financial Officer at Cytosorbents Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On August 28, 2023, the Company and Mr. D’Amico mutually agreed to terminate Mr. D’Amico’s employment with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923097790/0001104659-23-097790-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.